Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 1
2011 2
2012 2
2013 5
2016 3
2017 3
2018 1
2019 1
2020 3
2021 8
2022 16
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccination and HIV-1 acquisition.
Logunov DY, Livermore DM, Ornelles DA, Bayer W, Marques E, Czerkinsky C, Dolzhikova IV, Ertl HC. Logunov DY, et al. Lancet. 2022 Apr 9;399(10333):e34-e35. doi: 10.1016/S0140-6736(22)00332-4. Lancet. 2022. PMID: 35397866 Free PMC article. No abstract available.
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A.
Panova EA, Kleymenov DA, Shcheblyakov DV, Bykonia EN, Mazunina EP, Dzharullaeva AS, Zolotar AN, Derkaev AA, Esmagambetov IB, Sorokin II, Usachev EV, Noskov AN, Ivanov IA, Zatsepin TS, Dmitriev SE, Gushchin VA, Naroditsky BS, Logunov DY, Gintsburg AL. Panova EA, et al. Among authors: logunov dy. Front Immunol. 2023 Feb 14;14:1098302. doi: 10.3389/fimmu.2023.1098302. eCollection 2023. Front Immunol. 2023. PMID: 36865543 Free PMC article.
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Favorskaya IA, Shcheblyakov DV, Esmagambetov IB, Dolzhikova IV, Alekseeva IA, Korobkova AI, Voronina DV, Ryabova EI, Derkaev AA, Kovyrshina AV, Iliukhina AA, Botikov AG, Voronina OL, Egorova DA, Zubkova OV, Ryzhova NN, Aksenova EI, Kunda MS, Logunov DY, Naroditsky BS, Gintsburg AL. Favorskaya IA, et al. Among authors: logunov dy. Front Immunol. 2022 Feb 24;13:822159. doi: 10.3389/fimmu.2022.822159. eCollection 2022. Front Immunol. 2022. PMID: 35281053 Free PMC article.
Development of adenoviral vector-based mucosal vaccine against influenza.
Tutykhina IL, Logunov DY, Shcherbinin DN, Shmarov MM, Tukhvatulin AI, Naroditsky BS, Gintsburg AL. Tutykhina IL, et al. Among authors: logunov dy. J Mol Med (Berl). 2011 Apr;89(4):331-41. doi: 10.1007/s00109-010-0696-0. Epub 2010 Nov 21. J Mol Med (Berl). 2011. PMID: 21104066 Review.
Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study.
Tukhvatulin AI, Dolzhikova IV, Dzharullaeva AS, Grousova DM, Kovyrshina AV, Zubkova OV, Zorkov ID, Iliukhina AA, Shelkov AY, Erokhova AS, Popova O, Ozharovskaia TA, Zrelkin DI, Izhaeva FM, Shcheblyakov DV, Esmagambetov IB, Tokarskaya EA, Nikitenko NA, Lubenets NL, Khadorich EA, Gushchin VA, Borzakova SN, Vlasova AV, Osmanov IM, Gorev VV, Naroditsky BS, Logunov DY, Gintsburg AL. Tukhvatulin AI, et al. Among authors: logunov dy. Front Immunol. 2023 Aug 1;14:1228461. doi: 10.3389/fimmu.2023.1228461. eCollection 2023. Front Immunol. 2023. PMID: 37600800 Free PMC article. Clinical Trial.
In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1.
Pochtovyi AA, Kustova DD, Siniavin AE, Dolzhikova IV, Shidlovskaya EV, Shpakova OG, Vasilchenko LA, Glavatskaya AA, Kuznetsova NA, Iliukhina AA, Shelkov AY, Grinkevich OM, Komarov AG, Logunov DY, Gushchin VA, Gintsburg AL. Pochtovyi AA, et al. Among authors: logunov dy. Vaccines (Basel). 2023 Sep 28;11(10):1533. doi: 10.3390/vaccines11101533. Vaccines (Basel). 2023. PMID: 37896937 Free PMC article.
Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern.
Siniavin AE, Novikov MS, Gushchin VA, Terechov AA, Ivanov IA, Paramonova MP, Gureeva ES, Russu LI, Kuznetsova NA, Shidlovskaya EV, Luyksaar SI, Vasina DV, Zolotov SA, Zigangirova NA, Logunov DY, Gintsburg AL. Siniavin AE, et al. Among authors: logunov dy. Int J Mol Sci. 2022 Sep 5;23(17):10171. doi: 10.3390/ijms231710171. Int J Mol Sci. 2022. PMID: 36077564 Free PMC article.
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case.
Mukhina OA, Fomina DS, Parshin VV, Gushchin VA, Dolzhikova IV, Shchetinin AM, Chudakov DM, Alekseeva E, Korostin D, Bazykin GA, Klink G, Logunov DY, Lysenko MA. Mukhina OA, et al. Hum Vaccin Immunother. 2022 Nov 30;18(6):2101334. doi: 10.1080/21645515.2022.2101334. Epub 2022 Aug 1. Hum Vaccin Immunother. 2022. PMID: 35914217 Free PMC article.
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Esmagambetov IB, Ryabova EI, Derkaev AA, Shcheblyakov DV, Dolzhikova IV, Favorskaya IA, Grousova DM, Dovgiy MA, Prokofiev VV, Gosudarev AI, Byrikhina DV, Zorkov ID, Iliukhina AA, Kovyrshina AV, Shelkov AY, Naroditsky BS, Logunov DY, Gintsburg AL. Esmagambetov IB, et al. Among authors: logunov dy. Front Immunol. 2023 Mar 30;14:1129245. doi: 10.3389/fimmu.2023.1129245. eCollection 2023. Front Immunol. 2023. PMID: 37063833 Free PMC article.
Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance.
Shkoda AS, Gushchin VA, Ogarkova DA, Stavitskaya SV, Orlova OE, Kuznetsova NA, Keruntu EN, Pochtovyi AA, Pukhov AV, Kleymenov DA, Krzhanovsky VG, Vasina DV, Shkuratova NV, Shidlovskaya EV, Gorbunov AL, Kustova DD, Mazurina EA, Kozlova SR, Soboleva AV, Grigoriev IV, Pankratyeva LL, Odintsova AS, Belyaeva ED, Bessonova AA, Vasilchenko LA, Lupu IP, Adgamov RR, Tkachuk AP, Tokarskaya EA, Logunov DY, Gintsburg AL. Shkoda AS, et al. Among authors: logunov dy. Vaccines (Basel). 2022 Jun 13;10(6):938. doi: 10.3390/vaccines10060938. Vaccines (Basel). 2022. PMID: 35746546 Free PMC article.
52 results